These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 8152234)

  • 21. Development of bFGF-chitosan matrices and their interactions with human dermal fibroblast cells.
    Lefler A; Ghanem A
    J Biomater Sci Polym Ed; 2009; 20(10):1335-51. PubMed ID: 19622275
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Silver nanoparticles in therapeutics: development of an antimicrobial gel formulation for topical use.
    Jain J; Arora S; Rajwade JM; Omray P; Khandelwal S; Paknikar KM
    Mol Pharm; 2009; 6(5):1388-401. PubMed ID: 19473014
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro toxicity of topical antimicrobial agents to human fibroblasts.
    McCauley RL; Linares HA; Pelligrini V; Herndon DN; Robson MC; Heggers JP
    J Surg Res; 1989 Mar; 46(3):267-74. PubMed ID: 2921865
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nuclear factor kappaB activity is essential for matrix metalloproteinase-1 and -3 upregulation in rabbit dermal fibroblasts.
    Bond M; Baker AH; Newby AC
    Biochem Biophys Res Commun; 1999 Oct; 264(2):561-7. PubMed ID: 10529402
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Silver aids healing in the sterile skin wound: experimental studies in the laboratory rat.
    Lansdown AB; Sampson B; Laupattarakasem P; Vuttivirojana A
    Br J Dermatol; 1997 Nov; 137(5):728-35. PubMed ID: 9415232
    [TBL] [Abstract][Full Text] [Related]  

  • 26. FGF-2, IL-1beta and TGF-beta regulate fibroblast expression of S100A8.
    Rahimi F; Hsu K; Endoh Y; Geczy CL
    FEBS J; 2005 Jun; 272(11):2811-27. PubMed ID: 15943814
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of age and hypoxia on TGFbeta1 receptor expression and signal transduction in human dermal fibroblasts: impact on cell migration.
    Mogford JE; Tawil N; Chen A; Gies D; Xia Y; Mustoe TA
    J Cell Physiol; 2002 Feb; 190(2):259-65. PubMed ID: 11807830
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Second-degree burns: a comparative, multicenter, randomized trial of hyaluronic acid plus silver sulfadiazine vs. silver sulfadiazine alone.
    Costagliola M; Agrosì M
    Curr Med Res Opin; 2005 Aug; 21(8):1235-40. PubMed ID: 16083533
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential regulation of cytokine and receptor transcript expression in human corneal and limbal fibroblasts by epidermal growth factor, transforming growth factor-alpha, platelet-derived growth factor B, and interleukin-1 beta.
    Li DQ; Tseng SC
    Invest Ophthalmol Vis Sci; 1996 Sep; 37(10):2068-80. PubMed ID: 8814146
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of topically applied silver sulfadiazine on fibroblast cell proliferation and biomechanical properties of the wound.
    Lee AR; Moon HK
    Arch Pharm Res; 2003 Oct; 26(10):855-60. PubMed ID: 14609135
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential in vitro responses of elastin expression to basic fibroblast growth factor and transforming growth factor beta 1 in upper, middle and lower dermal fibroblasts.
    Tajima S; Izumi T
    Arch Dermatol Res; 1996 Nov; 288(12):753-6. PubMed ID: 8950455
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Wound therapy: growth factors as agents to promote healing.
    Meyer-Ingold W
    Trends Biotechnol; 1993 Sep; 11(9):387-92. PubMed ID: 7764085
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical studies on growth factors in pressure sores: preliminary report.
    Robson MC; Phillips LG; Heggers JP; McPherson MA; Heiner LS
    Prog Clin Biol Res; 1991; 365():95-102. PubMed ID: 1862156
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of wound contraction by topical antimicrobials.
    Leitch IO; Kucukcelebi A; Robson MC
    Aust N Z J Surg; 1993 Apr; 63(4):289-93. PubMed ID: 8311815
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Topical sulfadiazine silver for bullous pemphigoid.
    Chadwick JM; Downham TF
    Arch Dermatol; 1978 May; 114(5):803. PubMed ID: 348121
    [No Abstract]   [Full Text] [Related]  

  • 36. [Effect of recombinant human epidermal growth factor on the expansion of human skin in vitro].
    Sun T; Wu Z; Zhou B
    Zhonghua Zheng Xing Shao Shang Wai Ke Za Zhi; 1996 Nov; 12(6):431-2. PubMed ID: 9387433
    [TBL] [Abstract][Full Text] [Related]  

  • 37. bFGF and collagen matrix hydrogel attenuates burn wound inflammation through activation of ERK and TRK pathway.
    Chakrabarti S; Mazumder B; Rajkonwar J; Pathak MP; Patowary P; Chattopadhyay P
    Sci Rep; 2021 Feb; 11(1):3357. PubMed ID: 33558597
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ionic silver functionalized ovine forestomach matrix - a non-cytotoxic antimicrobial biomaterial for tissue regeneration applications.
    Karnik T; Dempsey SG; Jerram MJ; Nagarajan A; Rajam R; May BCH; Miller CH
    Biomater Res; 2019; 23():6. PubMed ID: 30834142
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A pharmacological and toxicological profile of silver as an antimicrobial agent in medical devices.
    Lansdown AB
    Adv Pharmacol Sci; 2010; 2010():910686. PubMed ID: 21188244
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytoprotection of human dermal fibroblasts against silver sulfadiazine using recombinant growth factors.
    McCauley RL; Li YY; Chopra V; Herndon DN; Robson MC
    J Surg Res; 1994 Apr; 56(4):378-84. PubMed ID: 8152234
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.